SFDA CEO: Hajj Challenges Drive Innovation and Improve Regulatory Oversight
Jeddah, November 09, 2026, SPA -- CEO of the Saudi Food and Drug Authority (SFDA) Prof. Hisham Saad Aljadhey described serving pilgrims as a great honor bestowed on Saudi Arabia by Allah and an ongoing responsibility to improve services for visitors to the Two Holy Mosques, noting that each Hajj season offers an opportunity to make progress, each challenge drives innovation, and each achievement lays the groundwork for greater ambitions.
Aljadhey made the remarks during a panel discussion on the health system's readiness to provide care for pilgrims at the sixth Hajj Conference and Exhibition in Jeddah. The Ministry of Hajj and Umrah organized the event under the theme "From Makkah to the World," in cooperation with the Pilgrim Experience Program, one of the Saudi Vision 2030 programs. Senior officials and dignitaries, heads of Hajj missions, and representatives of Hajj affairs offices from across the Islamic world attended.
Aljadhey highlighted the SFDA's use of artificial intelligence in RASID, a tool that verifies controlled medications carried by Hajj pilgrims and supports more than 50 languages. The tool saved inspectors more than 1,500 working hours during the last Hajj season. He also discussed ProVerifier, which identifies products and checks their details against regulatory records, reducing verification time by up to 98%.
He said the tools combine inspectors' expertise with artificial intelligence to make oversight more proactive and efficient, improve product safety, and simplify procedures. He added that the SFDA will continue to develop and expand its use of these technologies to meet the requirements of future Hajj seasons.